Advertisement
Organisation › Details
University of Tübingen, Natural and Medical Sciences Institute (NMI)
The NMI Natural and Medical Sciences Institute at the University of Tübingen is an extramural research institution, based at the interface of life sciences and material sciences. Since its foundation in 1985, research is conducted application-oriented. At the NMI an interdisciplinary team of scientists is developing new technologies in the areas of pharma and biotechnology, biomedical technology, and surface and materials technology. Personalization, biologization, miniaturization and digitalization are both the goal of NMIs work and the guiding principles of the research being carried out there. *
Start | 1985-01-01 established | |
Group | University of Tübingen (Eberhard-Karls-Universität) | |
Industry | bio sensor | |
Person | Schenke-Layland, Katja (Univ Tübingen 201805 Prof + Managing Director of NMI) | |
Person 2 | Hämmerle, Hugo (Univ Tübingen 201204 Prof + Head of NMI) | |
Region | Reutlingen | |
Country | Germany | |
Street | 55 Markwiesenstr. | |
City | 72770 Reutlingen | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | D: 101 to 500 (2018-05-31) |
* Document for »About Section«: Proteona Pte. Ltd.. (23/3/20). "Press Release: One More Step towards True Precision Medicine. Proteona, Synovo, and NMI Announced Collaboration on a Single Cell Multi-omics Profiling Platform for Patient-derived Micro-tumors". Singapore. | ||
Record changed: 2023-12-30 |
Advertisement
More documents for University of Tübingen (Eberhard-Karls-Universität)
- [1] Boehringer Ingelheim. (10/20/22). "Press Release: University of Tübingen and Boehringer Ingelheim Join Forces to Lead AI and Data Science R&D for New Medical Breakthroughs". Tübingen & Ingelheim....
- [2] SHS Gesellschaft für Beteiligungsmanagement mbH. (8/18/22). "Press Release: SHS Appoints Manfred Ulmer-Weber to the Management Board". Tübingen....
- [3] Corat Therapeutics GmbH. (6/22/21). "Press Release: CORAT Antibody COR-101 Binds and Inhibits all B.1.617 SARS-CoV-2 Variants, Including the Fast Proliferating “delta” Variant". Braunschweig....
- [4] Cytosurge AG. (3/24/21). "Press Release: Cytosurge’s FluidFM Technology Facilitates Multiplex CRISPR Editing and Monoclonal Cell Line Development in less than Three Weeks". Zürich....
- [5] NMI TT Pharmaservices. (8/6/19). "Press Release: LI-COR Biosciences Introduces DigiWest to Accelerate Targeted Therapeutics Development". Lincoln, NE....
- [6] ERS Genomics Ltd.. (5/31/18). "Press Release: ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to NMI and NMI TT Pharmaservices". Dublin & Reutlingen....
- [7] NMI TT Pharmaservices. (9/11/17). "Press Release: NMI TT Takes Over Global Zeptosens RPPA Chip Supply". Reutlingen & Berlin....
- [8] NMI TT Pharmaservices. (6/22/17). "Press Release: NMI TT Pharmaservices and Charité Awarded Grant for Development of Protein Profiling for Individualization of Tumor Therapy". Berlin....
- [9] Bruker Corporation. (6/1/17). "Press Release: Bruker Introduces New Solutions for Microbial Strain Typing, Hospital Hygiene and Infection Control at the ASM Microbe 2017 Meeting". New Orleans, LA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top